Recombinant Influenza A virus NEP Protein ，His

The study of NEP (Neutral Endopeptidase), a membrane-bound zinc-dependent metalloprotease, has gained significant attention in recent years due to its critical roles in various physiological and pathological processes. NEP is involved in the degradation of bioactive peptides, including neuropeptides, natriuretic peptides, and angiotensin, thus playing an essential role in regulating blood pressure, neurotransmission, and immune responses. Dysregulation of NEP activity has been implicated in various diseases, including cardiovascular disorders, neurodegenerative diseases, and cancer. The characterization of NEP's structure and function is vital for understanding its mechanism of action and therapeutic potential. Researchers have focused on NEP's enzymatic properties, substrate specificity, and the regulatory pathways that modulate its activity. Additionally, NEP is a promising target for drug development, with efforts directed towards designing NEP inhibitors and modulators that could enhance or inhibit its activity for therapeutic purposes. Advances in molecular biology and protein engineering techniques have facilitated the generation of NEP recombinant proteins, enabling in-depth studies of its functionality and interactions with different ligands, paving the way for innovative therapeutic strategies. Overall, NEP research holds promise for elucidating the complex roles of peptide signaling in health and disease, providing potential avenues for innovative treatments and interventions.